Nair Vinay’s DexCom DXCM Stock Holding History

Nair Vinay’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$1.37M	Buy	68,396 +50,116	+274%	+$880K	1.71%	7
2015 Q1	$285K	Buy	+18,280	New	+$276K	0.2%	203

Other funds holding DXCM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Nair Vinay's DXCM Position: Q2 2015 in Review

Nair Vinay increased its DexCom (DXCM) stake by 274% in Q2 2015, buying an estimated $880K and bringing the position to 68,396 shares worth $1.37M. The position accounts for 1.71% of the portfolio, ranked #7.

Nair Vinay first reported a position in DXCM in Q1 2015 and has held it in 2 quarters since. 257 funds tracked by Wall St. Rank hold DXCM as of Q2 2015.

Nair Vinay held 68,396 shares of DexCom worth $1.37M as of Q2 2015.
Nair Vinay bought 50,116 DexCom shares in Q2 2015, an estimated $880K.
DexCom made up 1.71% of Nair Vinay's portfolio in Q2 2015, its #7 holding.
Nair Vinay first reported a position in DexCom in Q1 2015 and has held it in 2 quarters since.
257 funds tracked by Wall St. Rank held DexCom as of Q2 2015.

Based on Nair Vinay's 13F filing for Q2 2015, filed 12 Aug 2015.